Variable mean ± SD, n (%), median (min-max) | Total SLE patients (n = 103) |
---|---|
Age at diagnosis (years) | 24.82 ± 8.49 |
Diseases duration (years) | 4 (1–39) |
Clinical manifestations | |
Psychiatric diagnosis | 11 (10.7) |
Seizures | 11 (10.7) |
Stroke | 6 (5.8) |
Biopsy proven nephritis | 12 (11.7) |
Dialysis | 3 (2.9) |
Disease activity (SLEDAI) | |
No Mild Moderate Sever | 19 (18.4) 37 (35.9) 39 (37.9) 8 (7.8) |
SLE medication classes | |
Steroids | 83 (80.6) |
Antimalarials | 56 (54.4) |
Azathioprine | 54 (52.4) |
Mycophenolate Mofetil | 23 (22.3) |
Methotrexate | 21 (20.4) |
Biologics | 9 (8.7) |